Fosamax Side Effects |
|
Lawyers Represent People Harmed by Fosamax |
|
Fosamax Associated With Increased Risk of Femur Fractures |
|
 |
March 10, 2010—The FDA announced it initiated a safety review to address the increased risk of femur fractures among patients taking Fosamax. The announcement followed two studies presented at the annual meeting for the American Academy of Orthopaedic Surgeons that indicated the drugs might adversely affect bone quality and increase risk of femur fracture when used for four or more years. |
Fosamax Linked to Osteonecrosis of the Jaw |
|
Fosamax belongs to a class of drugs known as bisphosphonates that are widely prescribed to post-menopausal women. Fosamax was approved by the FDA to treat or prevent osteoporosis or bone loss in women. These medications are intended to inhibit osteoclasts, cells that cause the breakdown of bone, thereby making the bones thicker and less likely to break. In some situations, Fosamax can have the opposite effect. Fosamax has been associated with osteonecrosis of the jaw, a condition where the jaw essentially rots away. The FDA concluded that labels accompanying bisphosphonates should warn patients of the risk of osteonecrosis. In August 2005, the manufacturer of Zometa and Aredia, drugs similar to Fosamax, added such a warning. As of May 2006, Merck, the manufacturer of Fosamax, has failed to include a warning on the label for osteonecrosis. The only warning related to the condition is included on page 13 of a 22 page report given only to pharmacies, a warning clearly inadequate given the risk. Merck has been under fire for failing to warn physicians and patients of the serious risk presented by Vioxx, another drug manufactured by the company. Vioxx was withdrawn from the worldwide market in September 2004, several years after the company was aware that the drug greatly increased the risk of heart attack and strokes in patients. |
|
Fosamax Lawsuit |
|
|
April 10, 2006—A Florida woman filed a lawsuit against Merck, the manufacturer of Fosamax, alleging the drug caused her to develop osteonecrosis. The condition caused her mouth to rot and exposed bone in her jaw. The woman used Fosamax for six years and asserts that Merck withheld information about the side effects of Fosamax. As of May 2006, fifteen women allegedly harmed by Fosamax have filed lawsuits against the company to recover compensation for their injuries. |
What You Should Do |
|
 |
Your Health |
| If you or a loved one is taking Fosamax and are concerned about the potential side effects, promptly consult your physician for an evaluation. | |
Your Legal Rights |
|
If you have been injured as a result of Fosamax, you may be entitled to compensation. You should act immediately to contact a lawyer experienced in matters involving dangerous pharmaceuticals. |
|
Our Lawyers Can Help |
|
 |
O'Steen & Harrison, PLC presently is handling legal claims on behalf of those injured by Fosamax. We invite you to contact us for a free, confidential consultation about your legal rights. We will represent patients throughout the United States. We can help you, too, wherever you live. For free answers to your questions about the Fosamax lawsuit, please call us toll-free at 1-800-883-8888 or complete this online contact form. |
O'Steen & Harrison, PLC |
300 W. Clarendon Ave., Suite 400 800.883.8888 |
Current Consumer Cases |
Contact Us |
Why You Should Choose Us |
We have represented thousands of people, including some of the largest and most important injury cases ever brought in the United States. In the single largest damages case in the history of the world, our attorneys were selected by the Arizona Attorney General as the only Arizona law firm to represent the State against American tobacco companies. As a result, Arizona taxpayers will receive more than three billion dollars to cover the costs of treating tobacco-related illnesses, maintain educational programs to prevent young people from smoking, and fund other important State programs. |
Fosamax News |
Merck Hit With $8 Million Verdict in Fosamax Trial FDA Will Review Fosamax for Safety High Stakes for Merck in Litigation on Fosamax
|